SI2340506T1 - Biomarkerji za pljučni rak in njihove uporabe - Google Patents
Biomarkerji za pljučni rak in njihove uporabeInfo
- Publication number
- SI2340506T1 SI2340506T1 SI200931363T SI200931363T SI2340506T1 SI 2340506 T1 SI2340506 T1 SI 2340506T1 SI 200931363 T SI200931363 T SI 200931363T SI 200931363 T SI200931363 T SI 200931363T SI 2340506 T1 SI2340506 T1 SI 2340506T1
- Authority
- SI
- Slovenia
- Prior art keywords
- lung cancer
- cancer biomarkers
- biomarkers
- lung
- cancer
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
- G06F17/10—Complex mathematical operations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Theoretical Computer Science (AREA)
- Mathematical Physics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Databases & Information Systems (AREA)
- Algebra (AREA)
- Mathematical Analysis (AREA)
- Mathematical Optimization (AREA)
- Plant Pathology (AREA)
- Pure & Applied Mathematics (AREA)
- Computational Mathematics (AREA)
- Software Systems (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9559308P | 2008-09-09 | 2008-09-09 | |
| US15283709P | 2009-02-16 | 2009-02-16 | |
| PCT/US2009/056399 WO2010030697A1 (en) | 2008-09-09 | 2009-09-09 | Lung cancer biomarkers and uses thereof |
| EP09813557.7A EP2340506B1 (en) | 2008-09-09 | 2009-09-09 | Lung cancer biomarkers and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2340506T1 true SI2340506T1 (sl) | 2016-02-29 |
Family
ID=42005456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200931363T SI2340506T1 (sl) | 2008-09-09 | 2009-09-09 | Biomarkerji za pljučni rak in njihove uporabe |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2340506B1 (https=) |
| JP (1) | JP5701212B2 (https=) |
| KR (1) | KR101658347B1 (https=) |
| CN (2) | CN102209968B (https=) |
| AU (2) | AU2009291811B2 (https=) |
| CA (3) | CA3152591C (https=) |
| DK (1) | DK2340506T3 (https=) |
| ES (1) | ES2559758T3 (https=) |
| GB (1) | GB2478441B (https=) |
| HK (1) | HK1204062A1 (https=) |
| HR (1) | HRP20160127T1 (https=) |
| MX (1) | MX2011002322A (https=) |
| SI (1) | SI2340506T1 (https=) |
| WO (1) | WO2010030697A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| WO2012006632A2 (en) * | 2010-07-09 | 2012-01-12 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| KR101900016B1 (ko) | 2009-03-12 | 2018-09-20 | 캔서 프리벤션 앤 큐어, 리미티드 | 폐 질환의 동정, 평가, 예방 및 치료 방법과, 성별에 기초하는 질환의 동정, 평가, 예방 및 치료를 포함하는 상기 방법의 키트 |
| SG187045A1 (en) | 2010-08-13 | 2013-02-28 | Somalogic Inc | Pancreatic cancer biomarkers and uses thereof |
| CA2832480C (en) * | 2011-04-07 | 2022-05-31 | The Scripps Research Institute | High-throughput screening for compounds modulating expression of cellular macromolecules |
| EP3825693A1 (en) * | 2011-04-29 | 2021-05-26 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| CA3064363C (en) * | 2011-10-24 | 2022-05-17 | Somalogic, Inc. | Non-small cell lung cancer biomarkers and uses thereof |
| US11913957B2 (en) | 2011-12-21 | 2024-02-27 | Biodesix, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| US9201044B2 (en) | 2011-12-21 | 2015-12-01 | Integrated Diagnostics, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| US9304137B2 (en) | 2011-12-21 | 2016-04-05 | Integrated Diagnostics, Inc. | Compositions, methods and kits for diagnosis of lung cancer |
| WO2013121374A2 (en) * | 2012-02-17 | 2013-08-22 | Koninklijke Philips N.V. | Acute lung injury (ali)/acute respiratory distress syndrome (ards) assessment and monitoring |
| WO2014074682A1 (en) | 2012-11-07 | 2014-05-15 | Somalogic, Inc. | Chronic obstructive pulmonary disease (copd) biomarkers and uses thereof |
| BR112016010322A2 (pt) * | 2013-11-07 | 2017-08-08 | Medial Res Ltd | Método computadorizado de avaliação de risco de câncer de pulmão, meio legível por computador, sistema de avaliação de câncer de pulmão, e método de geração de um classificador para avaliação de risco de câncer de pulmão |
| JP6857185B2 (ja) * | 2015-09-11 | 2021-04-14 | アプタマー サイエンス インコーポレイテッドＡｐｔａｍｅｒ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． | 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法 |
| FR3050269B1 (fr) * | 2016-04-15 | 2018-05-11 | Ecole Superieure De Physique Et De Chimie Industrielles De La Ville De Paris (Espci) | Procede de selection et de recuperation de produits et systeme associe |
| CN105823665A (zh) * | 2016-05-13 | 2016-08-03 | 北京九州柏林生物科技有限公司 | 生物组织样本制备套液 |
| AU2017281099A1 (en) | 2016-06-21 | 2019-01-03 | The Wistar Institute Of Anatomy And Biology | Compositions and methods for diagnosing lung cancers using gene expression profiles |
| JP6280997B1 (ja) * | 2016-10-31 | 2018-02-14 | 株式会社Preferred Networks | 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法 |
| CN110709936A (zh) | 2017-04-04 | 2020-01-17 | 肺癌蛋白质组学有限责任公司 | 用于早期肺癌预后的基于血浆的蛋白质概况分析 |
| KR102633621B1 (ko) | 2017-09-01 | 2024-02-05 | 벤 바이오사이언시스 코포레이션 | 진단 및 치료 모니터링용 바이오마커로서의 당펩티드의 식별 및 용도 |
| CA3083097A1 (en) | 2017-11-22 | 2019-05-31 | Gritstone Oncology, Inc. | Reducing junction epitope presentation for neoantigens |
| US12227808B2 (en) | 2017-12-19 | 2025-02-18 | The Wistar Institute Of Anatomy And Biology | Compostions and methods for diagnosing lung cancers using gene expression profiles |
| EP3810563A4 (en) * | 2018-06-22 | 2022-03-23 | Somalogic, Inc. | IMPROVED PROTEOMIC MULTIPLEX TESTS |
| JP7691373B2 (ja) * | 2019-06-21 | 2025-06-11 | ナショナル ユニヴァーシティー オブ シンガポール | 肺癌の可能性を判定するための方法 |
| CN110579611B (zh) * | 2019-09-18 | 2023-01-31 | 郑州大学 | 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法 |
| CN111047609B (zh) * | 2020-03-13 | 2020-07-24 | 北京深睿博联科技有限责任公司 | 肺炎病灶分割方法和装置 |
| WO2022073502A1 (zh) * | 2020-10-10 | 2022-04-14 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 生物标志物在制备肺癌检测试剂中的用途和方法 |
| CN112557514B (zh) * | 2020-12-22 | 2021-09-21 | 中国海洋大学 | 手持式海底沉积物样品剖面声学全自动测量装置 |
| WO2025137139A1 (en) * | 2023-12-18 | 2025-06-26 | Caris Mpi, Inc. | Dynamic tissue typing |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596503B1 (en) * | 2000-08-18 | 2003-07-22 | East Carolina University | Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| NZ528205A (en) * | 2001-03-12 | 2006-09-29 | Monogen Inc | Cell-based detection and differentiation of disease status in a cytological sample using a panel comprising a plurality of probes |
| US20030190602A1 (en) * | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| CA2444691A1 (en) * | 2001-04-18 | 2002-10-31 | Protein Design Labs, Inc. | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| US8014952B2 (en) * | 2002-12-18 | 2011-09-06 | Queen Elizabeth Hospital | Serum biomarkers in lung cancer |
| CN1225477C (zh) * | 2003-03-28 | 2005-11-02 | 上海市疾病预防控制中心 | 肺癌早期血清特异蛋白及其应用 |
| CN1455257A (zh) * | 2003-05-23 | 2003-11-12 | 北京师范大学 | 一种利用表面修饰蛋白芯片进行肺癌诊断方法 |
| ATE496142T1 (de) * | 2004-03-23 | 2011-02-15 | Oncotherapy Science Inc | Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs |
| JP2005304497A (ja) * | 2004-03-25 | 2005-11-04 | Joji Inasawa | 特定の癌関連遺伝子を用いる癌の検出方法及び癌の抑制方法 |
| CA2578680C (en) * | 2004-04-15 | 2011-06-14 | University Of Florida Research Foundation, Inc. | Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining |
| AU2005236075A1 (en) * | 2004-04-26 | 2005-11-03 | Children's Medical Center Corporation | Platelet biomarkers for the detection of disease |
| MX2007001357A (es) * | 2004-08-02 | 2009-08-07 | Childrens Medical Center | Biomarcadores de plaquetas para cancer. |
| CN1873417A (zh) * | 2005-06-02 | 2006-12-06 | 中国医学科学院肿瘤医院肿瘤研究所 | 一种用于诊断肺癌的蛋白质芯片 |
| EP1969363B1 (en) * | 2005-12-22 | 2016-11-30 | Abbott Molecular Inc. | Methods and marker combinations for screening for predisposition to lung cancer |
| US7908091B2 (en) * | 2006-03-17 | 2011-03-15 | Prometheus Laboratories Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| CA2666584A1 (en) * | 2006-10-17 | 2008-04-24 | Synergenz Bioscience Limited | Methods and compositions for assessment of pulmonary function and disorders |
| US20110119776A1 (en) * | 2007-02-05 | 2011-05-19 | Wong Kwok-Kin | Methods of diagnosing and prognosing lung cancer |
| KR100846354B1 (ko) * | 2007-03-21 | 2008-07-15 | (주) 프로탄바이오 | 혈청 당단백질부터 분리한 폐암 진단용 마커 |
| US20100184773A1 (en) * | 2007-05-18 | 2010-07-22 | Heinz-Josef Lenz | Germline Polymorphisms in the Angiogenic Pathway Predict Tumor Recurrence in Cancer Therapy |
| US7888051B2 (en) * | 2007-09-11 | 2011-02-15 | Cancer Prevention And Cure, Ltd. | Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| WO2010003772A1 (en) * | 2008-06-16 | 2010-01-14 | Siemens Medical Solutions Diagnostics Gmbh | Method for predicting adverse response to erythropoietin in breast cancer treatment |
| US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| CA2789494C (en) * | 2010-02-10 | 2021-08-17 | The Regents Of The University Of California | Salivary biomarkers for lung cancer detection |
-
2009
- 2009-09-09 CA CA3152591A patent/CA3152591C/en active Active
- 2009-09-09 DK DK09813557.7T patent/DK2340506T3/en active
- 2009-09-09 GB GB1106053.0A patent/GB2478441B/en active Active
- 2009-09-09 CA CA3011730A patent/CA3011730C/en active Active
- 2009-09-09 ES ES09813557.7T patent/ES2559758T3/es active Active
- 2009-09-09 CN CN200980144620.XA patent/CN102209968B/zh active Active
- 2009-09-09 AU AU2009291811A patent/AU2009291811B2/en active Active
- 2009-09-09 CA CA2734535A patent/CA2734535C/en active Active
- 2009-09-09 CN CN201410477840.7A patent/CN104198709A/zh active Pending
- 2009-09-09 EP EP09813557.7A patent/EP2340506B1/en active Active
- 2009-09-09 WO PCT/US2009/056399 patent/WO2010030697A1/en not_active Ceased
- 2009-09-09 HR HRP20160127TT patent/HRP20160127T1/hr unknown
- 2009-09-09 KR KR1020117005305A patent/KR101658347B1/ko active Active
- 2009-09-09 JP JP2011526308A patent/JP5701212B2/ja active Active
- 2009-09-09 SI SI200931363T patent/SI2340506T1/sl unknown
- 2009-09-09 MX MX2011002322A patent/MX2011002322A/es active IP Right Grant
-
2015
- 2015-05-18 HK HK15104677.5A patent/HK1204062A1/xx unknown
- 2015-10-29 AU AU2015249113A patent/AU2015249113B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3152591C (en) | 2023-08-29 |
| GB2478441A (en) | 2011-09-07 |
| HK1204062A1 (en) | 2015-11-06 |
| KR101658347B1 (ko) | 2016-09-21 |
| EP2340506A1 (en) | 2011-07-06 |
| EP2340506B1 (en) | 2015-11-11 |
| CA2734535A1 (en) | 2010-03-18 |
| AU2015249113B2 (en) | 2017-09-07 |
| CA3011730C (en) | 2022-05-17 |
| AU2009291811B2 (en) | 2015-10-29 |
| GB2478441B (en) | 2013-03-27 |
| ES2559758T3 (es) | 2016-02-15 |
| JP2012502281A (ja) | 2012-01-26 |
| AU2015249113A1 (en) | 2015-11-12 |
| CN102209968B (zh) | 2016-05-04 |
| CA3152591A1 (en) | 2010-03-18 |
| EP2340506A4 (en) | 2012-02-15 |
| HK1153834A1 (en) | 2012-04-05 |
| WO2010030697A1 (en) | 2010-03-18 |
| CN104198709A (zh) | 2014-12-10 |
| AU2009291811A1 (en) | 2010-03-18 |
| KR20110063753A (ko) | 2011-06-14 |
| CN102209968A (zh) | 2011-10-05 |
| MX2011002322A (es) | 2011-05-10 |
| GB201106053D0 (en) | 2011-05-25 |
| DK2340506T3 (en) | 2016-02-08 |
| CA2734535C (en) | 2018-08-28 |
| JP5701212B2 (ja) | 2015-04-15 |
| HRP20160127T1 (hr) | 2016-03-11 |
| CA3011730A1 (en) | 2010-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2478441B (en) | Lung cancer biomarkers and uses thereof | |
| IL269454B (en) | Qualitative losses and their uses | |
| IL223295A0 (en) | Lung cancer biomarkers and uses thereof | |
| GB0719792D0 (en) | Cancer biomarkers | |
| IL202727A0 (en) | Covalent diabodies and uses thereof | |
| SG10201710447QA (en) | Pancreatic cancer biomarkers and uses thereof | |
| EP2373999A4 (en) | NEW BIOMARKERS | |
| IL231426A (en) | Biological markers for lung cancer and their uses | |
| AU321242S (en) | Inhaler | |
| PL2373675T3 (pl) | Reagenty funkcjonalizujące tiole oraz ich zastosowania | |
| GB0818660D0 (en) | Biomarkers | |
| GB0807214D0 (en) | Biomarkers | |
| GB0616230D0 (en) | Biomarkers and uses thereof | |
| GB0719527D0 (en) | Value determination | |
| GB0821912D0 (en) | Biomarkers | |
| GB0818658D0 (en) | Biomarkers | |
| HK1178251A (en) | Lung cancer biomarkers and uses thereof | |
| GB0720334D0 (en) | Cancer biomarker | |
| AU2009900954A0 (en) | Cancer Biomarkers and Uses Therefor | |
| GB0805084D0 (en) | Biomarkers | |
| GB0805081D0 (en) | Biomarkers | |
| GB0809105D0 (en) | Biomarkers | |
| GB0708064D0 (en) | Biomarker | |
| GB0708653D0 (en) | Inhaler | |
| AU315171S (en) | Inhaler |